These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 2227114)

  • 21. Lipid advanced glycosylation: pathway for lipid oxidation in vivo.
    Bucala R; Makita Z; Koschinsky T; Cerami A; Vlassara H
    Proc Natl Acad Sci U S A; 1993 Jul; 90(14):6434-8. PubMed ID: 8341651
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nitric oxide inhibition of lipoxygenase-dependent liposome and low-density lipoprotein oxidation: termination of radical chain propagation reactions and formation of nitrogen-containing oxidized lipid derivatives.
    Rubbo H; Parthasarathy S; Barnes S; Kirk M; Kalyanaraman B; Freeman BA
    Arch Biochem Biophys; 1995 Dec; 324(1):15-25. PubMed ID: 7503550
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Non-oxidative modification of native low-density lipoprotein by oxidized low-density lipoprotein.
    Yang M; Leake DS; Rice-Evans CA
    Biochem J; 1996 Jun; 316 ( Pt 2)(Pt 2):377-80. PubMed ID: 8687375
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pro-oxidant effects of lipoxygenase-derived peroxides on the copper-initiated oxidation of low-density lipoprotein.
    O'Leary VJ; Darley-Usmar VM; Russell LJ; Stone D
    Biochem J; 1992 Mar; 282 ( Pt 3)(Pt 3):631-4. PubMed ID: 1554346
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Low-density-lipoprotein (LDL)-bound flavonoids increase the resistance of LDL to oxidation and glycation under pathophysiological concentrations of glucose in vitro.
    Wu CH; Lin JA; Hsieh WC; Yen GC
    J Agric Food Chem; 2009 Jun; 57(11):5058-64. PubMed ID: 19489629
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Irreversibly glycated LDL induce oxidative and inflammatory state in human endothelial cells; added effect of high glucose.
    Toma L; Stancu CS; Botez GM; Sima AV; Simionescu M
    Biochem Biophys Res Commun; 2009 Dec; 390(3):877-82. PubMed ID: 19850013
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Glucose-modified low density lipoprotein enhances human monocyte chemotaxis.
    Millican SA; Schultz D; Bagga M; Coussons PJ; Müller K; Hunt JV
    Free Radic Res; 1998 May; 28(5):533-42. PubMed ID: 9702533
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The initiation of free radical peroxidation of low-density lipoproteins by glucose and its metabolite methylglyoxal: a common molecular mechanism of vascular wall injure in atherosclerosis and diabetes.
    Lankin V; Konovalova G; Tikhaze A; Shumaev K; Kumskova E; Viigimaa M
    Mol Cell Biochem; 2014 Oct; 395(1-2):241-52. PubMed ID: 24997046
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Changes of fructosamine content and their effects on platelet aggregation of glycosylated modification of low density lipoprotein in vitro].
    Tian H; Liang J; Zhang X
    Hua Xi Yi Ke Da Xue Xue Bao; 1995 Mar; 26(1):83-5. PubMed ID: 7657347
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Uric acid oxidation by peroxynitrite: multiple reactions, free radical formation, and amplification of lipid oxidation.
    Santos CX; Anjos EI; Augusto O
    Arch Biochem Biophys; 1999 Dec; 372(2):285-94. PubMed ID: 10600166
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The possible relevance of autoxidative glycosylation in glucose mediated alterations of proteins: an in vitro study on myofibrillar proteins.
    Lal S; Chithra P; Chandrakasan G
    Mol Cell Biochem; 1996 Jan; 154(2):95-100. PubMed ID: 8717422
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dynamics of the oxidation of low density lipoprotein induced by free radicals.
    Noguchi N; Gotoh N; Niki E
    Biochim Biophys Acta; 1993 Jul; 1168(3):348-57. PubMed ID: 8323975
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glucose autoxidation and protein modification. The potential role of 'autoxidative glycosylation' in diabetes.
    Wolff SP; Dean RT
    Biochem J; 1987 Jul; 245(1):243-50. PubMed ID: 3117042
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lipid peroxidation and its role in atherosclerosis.
    Esterbauer H; Wäg G; Puhl H
    Br Med Bull; 1993 Jul; 49(3):566-76. PubMed ID: 8221023
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aminoguanidine inhibits oxidative modification of low density lipoprotein protein and the subsequent increase in uptake by macrophage scavenger receptors.
    Picard S; Parthasarathy S; Fruebis J; Witztum JL
    Proc Natl Acad Sci U S A; 1992 Aug; 89(15):6876-80. PubMed ID: 1495978
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Glucose-induced enhancement of hemin-catalyzed LDL oxidation in vitro and in vivo.
    Julius U; Pietzsch J
    Antioxid Redox Signal; 2005; 7(11-12):1507-12. PubMed ID: 16356114
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The salicylate metabolite gentisic acid, but not the parent drug, inhibits glucose autoxidation-mediated atherogenic modification of low density lipoprotein.
    Exner M; Hermann M; Hofbauer R; Kapiotis S; Speiser W; Held I; Seelos C; Gmeiner BM
    FEBS Lett; 2000 Mar; 470(1):47-50. PubMed ID: 10722843
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High density lipoprotein subclasses inhibit low density lipoprotein oxidation.
    Singh K; Chander R; Kapoor NK
    Indian J Biochem Biophys; 1997 Jun; 34(3):313-8. PubMed ID: 9425752
    [TBL] [Abstract][Full Text] [Related]  

  • 39. What is the effect of hyperglycemia on atherogenesis and can it be reversed by aminoguanidine?
    Bucala R
    Diabetes Res Clin Pract; 1996 Feb; 30 Suppl():123-30. PubMed ID: 8964186
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hemoglobin induced apolipoprotein B crosslinking in low-density lipoprotein peroxidation.
    Miller YI; Felikman Y; Shaklai N
    Arch Biochem Biophys; 1996 Feb; 326(2):252-60. PubMed ID: 8611031
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.